Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Merck
Merck
Merck still scouting for M&A deals, even after $10.8B takeover of Prometheus
Fierce Pharma
Tue, 08/1/23 - 10:19 pm
Merck
Prometheus Biosciences
M&A
Merck (MRK) Reports Q2 Loss, Tops Revenue Estimates
Yahoo/Zacks.com
Tue, 08/1/23 - 11:46 am
Merck
earnings
Big Pharma CEOs get candid about pricing and M&A
Pharma Voice
Mon, 07/31/23 - 10:03 am
Big Pharma
Pharma CEOs
drug pricing
M&A
JNJ
Merck
GSK
Merck's Keytruda meets main goal in late-stage breast cancer study
Reuters
Sat, 07/29/23 - 10:40 pm
Merck
Keytruda
clinical trials
breast cancer
Merck’s next-gen pneumococcal vaccine strides forward after two phase 3 wins
Fierce Biotech
Thu, 07/27/23 - 11:38 am
Merck
pneumococcal disease
vaccines
clinical trials
V116
Merck, insurers advance fight over cyberattack-related coverage to New Jersey Supreme Court
Fierce Pharma
Thu, 07/27/23 - 10:21 am
Merck
legal
cyberattack
cybersecurity
NotPetya
Moderna/Merck begins late-stage study of skin cancer vaccine combination
Yahoo/Reuters
Wed, 07/26/23 - 09:36 am
Moderna Therapeutics
Merck
MRNA
vaccines
skin cancer
Keytruda
clinical trials
Former Merck VP Nirdosh Jagota settles with SEC on insider trading charge
Fierce Pharma
Thu, 07/20/23 - 09:58 am
Merck
Pandion Therapeutics
SEC
insider trading
House Judiciary Committee Probes Big Pharma’s Potential Role in COVID-19 Censorship
BioSpace
Wed, 07/19/23 - 10:23 am
Pfizer
JNJ
Merck
Big Pharma
COVID-19
US Congress
Phase III Data Show Keytruda’s Promise in Earlier-Stage Cervical Cancer
BioSpace
Wed, 07/19/23 - 10:21 am
Merck
Keytruda
clinical trials
cervical cancer
Merck applies more pressure against IRA, asking for decision without trial in fight with US government
Fierce Pharma
Wed, 07/12/23 - 11:17 pm
Merck
Inflation Reduction Act
Bristol Myers' Opdivo stages comeback in bladder cancer, teeing up 2 'Merck' showdowns
Fierce Pharma
Wed, 07/12/23 - 09:30 am
Bristol Myers Squibb
Opdivo
bladder cancer
Merck
Merck’s New Jersey campus is getting a biotech makeover
BioPharma Dive
Wed, 07/12/23 - 09:29 am
Merck
New Jersey
Onyx Equities
Keytruda Keeps Racking Up Approvals and Clinical Wins in ’23
BioSpace
Thu, 07/6/23 - 11:30 am
Merck
Keytruda
oncology
cancer
Biopharma buyouts bounce back
EP Vantage
Wed, 07/5/23 - 10:17 am
M&A
Amgen
Astellas
Eli Lilly
GSK
Horizon Therapeutics
Merck
Novartis
Pfizer
Seagen
Pfizer's Talzenna snags broader prostate cancer nod than AstraZeneca and Merck's rival PARP med
Fierce Pharma
Thu, 06/22/23 - 10:12 am
Pfizer
FDA
prostate cancer
Talzenna
AstraZeneca
PARP inhibitors
Merck
Merck consolidates New Jersey operations at 'reimagined' headquarters in Rahway
Fierce Pharma
Wed, 06/21/23 - 10:57 pm
Merck
headquarters
New Jersey
After metastatic disease win, Merck's Keytruda flunks trial in early stomach cancer
Fierce Pharma
Tue, 06/20/23 - 09:39 pm
Merck
Keytruda
stomach cancer
BMS Follows Merck’s Lead, Sues Government Over Drug Pricing Negotiation
BioSpace
Mon, 06/19/23 - 11:41 am
Bristol Myers Squibb
Merck
legal
drug pricing
Medicare
Inflation Reduction Act
Merck secures Bridion patent protection through January 2026
BioSpace
Thu, 06/15/23 - 10:16 am
Merck
patents
Bridion
muscle relaxant reversal
Pages
« first
‹ previous
…
2
3
4
5
6
7
8
9
10
…
next ›
last »